Detailed Information
Cited 0 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
Belantamab mafodotin in patients with severely impaired renal function: a phase I, 2-part study to evaluate pharmacokinetics, safety and efficacy in patients with relapsed/refractory multiple myeloma
- Authors
- Shafi-Harji, Seema; Nugent, Courtney; Ferron-Brady, Geraldine; Delimpasi, Sosana; Dimopoulos, Meletios; Chen, Yunxin; Chng, Wee Joo; Lee, Jae Hoon; Ailawadhi, Sikander; Gowin, Krisstina; Arning, Michael; Struemper, Herbert
- Issue Date
- Sep-2023
- Publisher
- CIG MEDIA GROUP, LP
- Citation
- CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, v.23, pp S170 - S171
- Journal Title
- CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
- Volume
- 23
- Start Page
- S170
- End Page
- S171
- ISSN
- 2152-2650
2152-2669
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - ETC > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Related Researcher
- Lee, Jae Hoon
- College of Medicine (Department of Medicine)